vs
Side-by-side financial comparison of Dexcom (DXCM) and monday.com Ltd. (MNDY). Click either name above to swap in a different company.
Dexcom is the larger business by last-quarter revenue ($1.3B vs $704.0M, roughly 1.8× monday.com Ltd.). Dexcom runs the higher net margin — 21.2% vs 1.3%, a 19.9% gap on every dollar of revenue.
Dexcom, Inc. is an American multinational healthcare company that develops, manufactures, produces and distributes a line of continuous glucose monitoring (CGM) systems for diabetes management. It operates internationally with global headquarters and R&D center in San Diego, California, U.S.A. and manufacturing facilities in Mesa, Arizona, U.S.A.; Batu Kawan, Malaysia and Athenry, County Galway, Ireland.
Monday.com Ltd. is an Israeli-based cloud-based platform that allows users to create their own applications and project management software. The product was launched in 2014 and in July 2019, the company raised $150 million, based on a $1.9 billion valuation. The company went public in June 2021 and is based in Tel Aviv, Israel.
DXCM vs MNDY — Head-to-Head
Income Statement — Q1 FY2026 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.3B | $704.0M |
| Net Profit | $267.3M | $9.4M |
| Gross Margin | 62.9% | 89.6% |
| Operating Margin | 25.6% | -4.4% |
| Net Margin | 21.2% | 1.3% |
| Revenue YoY | 21.6% | — |
| Net Profit YoY | 153.6% | — |
| EPS (diluted) | $0.67 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $1.3B | — | ||
| Q4 25 | $1.3B | — | ||
| Q3 25 | $1.2B | $704.0M | ||
| Q2 25 | $1.2B | $453.0M | ||
| Q1 25 | $1.0B | $216.9M | ||
| Q4 24 | $1.1B | — | ||
| Q3 24 | $994.2M | $527.1M | ||
| Q2 24 | $1.0B | $337.9M |
| Q1 26 | $267.3M | — | ||
| Q4 25 | $267.3M | — | ||
| Q3 25 | $283.8M | $9.4M | ||
| Q2 25 | $179.8M | $21.4M | ||
| Q1 25 | $105.4M | $7.1M | ||
| Q4 24 | $151.7M | — | ||
| Q3 24 | $134.6M | $-14.2M | ||
| Q2 24 | $143.5M | $-21.7M |
| Q1 26 | 62.9% | — | ||
| Q4 25 | 62.9% | — | ||
| Q3 25 | 60.5% | 89.6% | ||
| Q2 25 | 59.5% | 89.6% | ||
| Q1 25 | 56.9% | 89.2% | ||
| Q4 24 | 58.9% | — | ||
| Q3 24 | 59.7% | 89.0% | ||
| Q2 24 | 62.4% | 89.2% |
| Q1 26 | 25.6% | — | ||
| Q4 25 | 25.6% | — | ||
| Q3 25 | 20.1% | -4.4% | ||
| Q2 25 | 18.4% | -0.7% | ||
| Q1 25 | 12.9% | -2.3% | ||
| Q4 24 | 17.0% | — | ||
| Q3 24 | 15.3% | -7.1% | ||
| Q2 24 | 15.7% | -10.3% |
| Q1 26 | 21.2% | — | ||
| Q4 25 | 21.2% | — | ||
| Q3 25 | 23.5% | 1.3% | ||
| Q2 25 | 15.5% | 4.7% | ||
| Q1 25 | 10.2% | 3.3% | ||
| Q4 24 | 13.6% | — | ||
| Q3 24 | 13.5% | -2.7% | ||
| Q2 24 | 14.3% | -6.4% |
| Q1 26 | $0.67 | — | ||
| Q4 25 | $0.67 | — | ||
| Q3 25 | $0.70 | — | ||
| Q2 25 | $0.45 | — | ||
| Q1 25 | $0.27 | — | ||
| Q4 24 | $0.37 | — | ||
| Q3 24 | $0.34 | — | ||
| Q2 24 | $0.35 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $917.7M | $1.4B |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $2.7B | $1.0B |
| Total Assets | $6.3B | $1.7B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $917.7M | — | ||
| Q4 25 | $917.7M | — | ||
| Q3 25 | $1.8B | $1.4B | ||
| Q2 25 | $1.2B | $1.7B | ||
| Q1 25 | $904.9M | $1.4B | ||
| Q4 24 | $606.1M | — | ||
| Q3 24 | $621.2M | $1.1B | ||
| Q2 24 | $939.2M | $1.3B |
| Q1 26 | $2.7B | — | ||
| Q4 25 | $2.7B | — | ||
| Q3 25 | $2.7B | $1.0B | ||
| Q2 25 | $2.6B | $1.2B | ||
| Q1 25 | $2.3B | $1.0B | ||
| Q4 24 | $2.1B | — | ||
| Q3 24 | $2.0B | $813.5M | ||
| Q2 24 | $2.4B | $910.1M |
| Q1 26 | $6.3B | — | ||
| Q4 25 | $6.3B | — | ||
| Q3 25 | $7.5B | $1.7B | ||
| Q2 25 | $7.3B | $2.0B | ||
| Q1 25 | $6.8B | $1.7B | ||
| Q4 24 | $6.5B | — | ||
| Q3 24 | $6.4B | $1.3B | ||
| Q2 24 | $6.8B | $1.5B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $234.4M |
| Free Cash FlowOCF − Capex | — | $224.6M |
| FCF MarginFCF / Revenue | — | 31.9% |
| Capex IntensityCapex / Revenue | — | 1.4% |
| Cash ConversionOCF / Net Profit | — | 25.02× |
| TTM Free Cash FlowTrailing 4 quarters | — | $608.3M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $294.0M | — | ||
| Q3 25 | $659.9M | $234.4M | ||
| Q2 25 | $303.0M | $147.7M | ||
| Q1 25 | $183.8M | $92.0M | ||
| Q4 24 | $301.4M | — | ||
| Q3 24 | $199.5M | $156.9M | ||
| Q2 24 | $279.4M | $90.3M |
| Q1 26 | — | — | ||
| Q4 25 | $192.1M | — | ||
| Q3 25 | $579.4M | $224.6M | ||
| Q2 25 | $208.9M | $141.8M | ||
| Q1 25 | $96.8M | $90.5M | ||
| Q4 24 | $176.8M | — | ||
| Q3 24 | $88.3M | $151.4M | ||
| Q2 24 | $213.3M | $85.6M |
| Q1 26 | — | — | ||
| Q4 25 | 15.3% | — | ||
| Q3 25 | 47.9% | 31.9% | ||
| Q2 25 | 18.1% | 31.3% | ||
| Q1 25 | 9.3% | 41.7% | ||
| Q4 24 | 15.9% | — | ||
| Q3 24 | 8.9% | 28.7% | ||
| Q2 24 | 21.2% | 25.3% |
| Q1 26 | — | — | ||
| Q4 25 | 8.1% | — | ||
| Q3 25 | 6.7% | 1.4% | ||
| Q2 25 | 8.1% | 1.3% | ||
| Q1 25 | 8.4% | 0.7% | ||
| Q4 24 | 11.2% | — | ||
| Q3 24 | 11.2% | 1.0% | ||
| Q2 24 | 6.6% | 1.4% |
| Q1 26 | — | — | ||
| Q4 25 | 1.10× | — | ||
| Q3 25 | 2.33× | 25.02× | ||
| Q2 25 | 1.69× | 6.91× | ||
| Q1 25 | 1.74× | 12.99× | ||
| Q4 24 | 1.99× | — | ||
| Q3 24 | 1.48× | — | ||
| Q2 24 | 1.95× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
